Conference Menu

Overview
Register
Day 1
Day 2
Download Brochure
Hotel & Travel
Sponsor & Exhibit
Floorplan
Posters
Press Pass
Request Information
Archives 



Corporate Sponsors:

Amarantus Bioscience 

 GYROS 

 

Ora 


Official Media Partner:

Bio-IT-

Word 


Lead Sponsoring Publications:

Gen 

nature 

The Scientist 

Science AAAS 


Sponsoring Publications:

Drug Discovery News  

Insight Pharma Reports 

OphthaBlueLogo 

 

PharmaVoice 


Web Partner:

Labroots   

Pharmcast  

Biospace  

einnews  

GenomeWeb  

FiercePharma  


Targeting Ocular Disorders - Overview




With the aging of the population, the need for treatments of ocular diseases and disorders has become more important than ever. Increasingly high incidences of age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and ocular inflammatory diseases demand better, more effective and innovative treatments. If we are to maintain the quality of life for this aging population, the preservation of vision is critical. This conference will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these quality of life threats.

Topics Include:

  • New disease pathways
  • Alternative drugs
  • Anti-inflammatories
  • Biologics
  • Bi-specific therapies
  • Novel therapeutics
  • Anti-angiogenics
  • Drugs in clinical trials

FEATURED PRESENTATION 

Systemic Administration of Anti-Ab mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model

Ian R. Catchpole, Ph.D., Topical BioPharm Discovery Research and Development, Glaxo-Smith Kline

 



By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs